All results

7 results for covid 19 research

• Adaptive COVID-19 Treatment Trial (ACTT)

  This study is an adaptive, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized…

  Ages

  18 Years - 99 Years

  Sexes

  All

• TREAT-MS

  FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) target the relapsing phase of MS but have minimal impact once the progressive phase has…

  Ages

  18 Years - 60 Years

  Sexes

  All

• RESOLVE - Lung

  This is a randomized, double-blind, placebo-controlled study with an open-label extension (OLE). This is a randomized, double-blind, placebo-controlled study…

  Ages

  18 Years - N/A

  Sexes

  All

• TN-31 JAKPOT T1D

  A multi-center, placebo-controlled, double blind, 1:1:1 randomized control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and…

  Ages

  12 Years - 35 Years

  Sexes

  All

• XTMab

  A phase 1b/2 study of XTMAB-16 in patients with pulmonary sarcoidosis ### Inclusion Criteria: 1. Participant between 18 to 80 years (inclusive) of age. 2.…

  Ages

  18 Years - 80 Years

  Sexes

  All

• Fasting ENHANCE

  Grounded in the principles of geroscience, the proposed Fasting ENHANCE study will test whether a time restricted eating (TRE) regimen can improve cognitive…

  Ages

  65 Years - N/A

  Sexes

  All

• A Study of ASP1002 in Adults for Treatment of Solid Tumors

  ASP1002 is a potential new treatment for people with certain solid tumors. Before ASP1002 is available as a treatment, the researchers need to understand how…

  Ages

  18 Years - N/A

  Sexes

  All